findmyKOL

Eric Maranda, MD

Basic profile

Dermatology

ORCIDNPI
RegionBillings, MT · WestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Eric Maranda is a Dermatology physician. OpenAlex indexes 47 publications with 610 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
47publications

Distinct works indexed by OpenAlex, matched via ORCID.

610citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

178 S 32nd St W Ste 3
Billings, MT 591026889

Telephone

406-702-1323

Provider last certified this registry record 8 Feb 2022.

View the NPPES registry record

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    37%
    Azole Antifungal17.2%
    Ketoconazole80%Fluconazole20%
    Part D171 patients
    Tetracycline-class Drug15.4%
    Doxycycline Monohydrate51%Doxycycline Hyclate49%
    Part D163 patients

    + 4 more classes in this area

  • Respiratory

    12.1%
    RNA Synthetase Inhibitor Antibacterial12.1%
    Mupirocin100%
    Part D255 patients
  • Cardiovascular

    11.1%
    Arteriolar Vasodilator9.2%
    Minoxidil100%
    Part D63 patients
    Corticosteroid1.3%
    Fluocinonide100%
    Part D20 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”